Healthcare provider profile · identity verified

Eugene Fellin, DO

Family Practice · FLEETWOOD, PA · NPI 1386635167

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	828	225
Amlodipine Besylate	Amlodipine Besylate	585	165
Lisinopril	Lisinopril	416	119
Levothyroxine Sodium	Levothyroxine Sodium	387	95
Simvastatin	Simvastatin	349	99
Metoprolol Succinate	Metoprolol Succinate	325	82
Omeprazole	Omeprazole	291	92
Metformin Hcl	Metformin Hcl	273	79
Tamsulosin Hcl	Tamsulosin Hcl	268	70
Losartan Potassium	Losartan Potassium	243	62
Pantoprazole Sodium	Pantoprazole Sodium	240	60
Eliquis	Apixaban	226	36
Escitalopram Oxalate	Escitalopram Oxalate	213	56
Gabapentin	Gabapentin	209	46
Furosemide	Furosemide	187	48
Rosuvastatin Calcium	Rosuvastatin Calcium	184	55
Alprazolam	Alprazolam	171	46
Hydrochlorothiazide	Hydrochlorothiazide	165	39
Sertraline Hcl	Sertraline Hcl	164	43
Jardiance	Empagliflozin	153	35
Zolpidem Tartrate	Zolpidem Tartrate	145	28
Tramadol Hcl	Tramadol Hcl	139	34
Synthroid	Levothyroxine Sodium	136	28
Clopidogrel	Clopidogrel Bisulfate	135	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	123	29
Metformin Hcl Er	Metformin Hcl	122	33
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	117	33
Metoprolol Tartrate	Metoprolol Tartrate	117	32
Potassium Chloride	Potassium Chloride	113	28
Allopurinol	Allopurinol	104	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	28
Pravastatin Sodium	Pravastatin Sodium	100	29
Bupropion Xl	Bupropion Hcl	92	28
Xarelto	Rivaroxaban	92	13
Montelukast Sodium	Montelukast Sodium	91	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	91	23
Ezetimibe	Ezetimibe	90	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	89	14
Fluoxetine Hcl	Fluoxetine Hcl	88	18
Valsartan	Valsartan	87	24
Meloxicam	Meloxicam	86	23
Fluticasone Propionate	Fluticasone Propionate	85	29
Albuterol Sulfate Hfa	Albuterol Sulfate	84	34
Carvedilol	Carvedilol	83	19
Hydralazine Hcl	Hydralazine Hcl	83	24
Clonazepam	Clonazepam	82	24
Alendronate Sodium	Alendronate Sodium	74	22
Venlafaxine Hcl Er	Venlafaxine Hcl	74	17
Duloxetine Hcl	Duloxetine Hcl	72	11
Finasteride	Finasteride	71	19
Glipizide	Glipizide	66	18
Pregabalin	Pregabalin	66	12
Trazodone Hcl	Trazodone Hcl	66	18
Citalopram Hbr	Citalopram Hydrobromide	65	17
Ozempic	Semaglutide	64	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	63	suppressed
Benazepril Hcl	Benazepril Hcl	63	18
Prednisone	Prednisone	62	32
Olmesartan Medoxomil	Olmesartan Medoxomil	58	17
Donepezil Hcl	Donepezil Hcl	57	13
Ropinirole Hcl	Ropinirole Hcl	57	suppressed
Famotidine	Famotidine	56	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	12
Paroxetine Hcl	Paroxetine Hcl	56	13
Glimepiride	Glimepiride	55	16
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	55	11
Valacyclovir	Valacyclovir Hcl	51	18
Fenofibrate	Fenofibrate	50	11
Trulicity	Dulaglutide	49	suppressed
Atenolol	Atenolol	48	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	13
Mirtazapine	Mirtazapine	46	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	44	13
Doxycycline Monohydrate	Doxycycline Monohydrate	43	39
Bisoprolol Fumarate	Bisoprolol Fumarate	42	13
Buspirone Hcl	Buspirone Hcl	42	12
Memantine Hcl	Memantine Hcl	42	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	41	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	13
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	38	suppressed
Lorazepam	Lorazepam	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	36	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Irbesartan	Irbesartan	34	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	33	suppressed
Naproxen	Naproxen	32	14
Mometasone Furoate	Mometasone Furoate	31	21
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	18
Ramipril	Ramipril	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	29	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Primidone	Primidone	27	suppressed
Amoxicillin	Amoxicillin	26	14
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	21
Morphine Sulfate	Morphine Sulfate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Telmisartan	Telmisartan	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Methylprednisolone	Methylprednisolone	20	15
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Torsemide	Torsemide	19	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Cephalexin	Cephalexin	17	11
Chlorthalidone	Chlorthalidone	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Fentanyl	Fentanyl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Azithromycin	Azithromycin	15	15
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Dulera	Mometasone/Formoterol	15	suppressed
Linzess	Linaclotide	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	13
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Testosterone	Testosterone	14	suppressed
Topiramate	Topiramate	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Temazepam	Temazepam	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error